Back to UBS Group AG UBS Group AG

PYXSPYXS
Showing 8 of 18 quarters

Position history for UBS Group AGUBS Group AG's holdings in PYXIS ONCOLOGY INC

UBS Group AG holds 254,124 shares of PYXS (PYXIS ONCOLOGY INC), worth $371,021 as of 2026-Q1. The position was decreased (-35.3% shares). PYXS represents 0.0% of UBS Group AG's portfolio.

Current Value

$371,021

Current Shares

254,124

Total Value Change

+$312,507

Total Shares Change

+236,446

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
254,124
-35.3%
$371,0210.0%$1.43
0
2025-Q4
Increased
392,766
+5.1%
$451,6810.0%$1.09
25
2025-Q3
Decreased
373,727
-5.7%
$829,6740.0%$2.20
0
2025-Q2
Decreased
396,096
-0.2%
$435,7060.0%$1.10
0
2025-Q1
Decreased
396,844
-11.2%
$388,9080.0%$1.06
0
2024-Q4
Increased
446,699
+1489.6%
$696,8510.0%$1.56
40
2024-Q3
Increased
28,102
+59.0%
$103,1340.0%$3.62
21
2024-Q2
Decreased
17,678
-37.4%
$58,5140.0%$3.31
0

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used